There was no significant difference in target-vessel failure between the Resolute and Xience V groups with bifurcation treatment ( 13.6 % vs 12.6 % ; P = .78 ) , and their incidence of definite-or-probable stent thrombosis was low and similar ( 1.1 % vs 0.5 % , respectively ; P = .62 ) .